Wolverine Trading’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,176
Closed -$370K 5481
2021
Q4
$370K Buy
8,176
+4,035
+97% +$211K ﹤0.01% 3857
2021
Q3
$251K Buy
+4,141
New +$315K ﹤0.01% 4983
2021
Q2
Sell
-3,615
Closed -$228K 6073
2021
Q1
$228K Buy
3,615
+759
+27% +$58.9K ﹤0.01% 4865
2020
Q4
$214K Buy
+2,856
New +$165K ﹤0.01% 4149
2020
Q1
Sell
-19,459
Closed -$436K 4675
2019
Q4
$408K Sell
19,459
-3,117
-14% -$71.5K ﹤0.01% 3259
2019
Q3
$493K Buy
+22,576
New +$625K ﹤0.01% 2643
2019
Q1
Sell
-15,621
Closed -$367K 4574
2018
Q4
$367K Sell
15,621
-13,849
-47% -$356K ﹤0.01% 2956
2018
Q3
$850K Buy
+29,470
New +$551K ﹤0.01% 2535

Other funds holding CDNA

Wolverine Trading's CDNA Position: Q1 2022 in Review

Wolverine Trading sold out of CareDx (CDNA) in Q1 2022, closing a stake of 8,176 shares — an estimated $370K sold.

Wolverine Trading first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $850K in Q3 2018. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Wolverine Trading reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 8,176 CareDx shares in Q1 2022, an estimated $370K.
  • Wolverine Trading first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • Wolverine Trading's CareDx position peaked at $850K in Q3 2018.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.